SKI Market

A+| A| A-|

Indian Indices

Sensex

74,563.92 -1,470.50
( -1.93%)

Global Indices

Nasdaq

46,583.62 -115.24
(-0.25%)

Dow Jones

6,653.27 -40.35
(-0.60%)

Hang Seng

53,838.16 -614.80
(-1.13%)

Nikkei 225

10,249.42 -55.73
(-0.54%)

Forex

USD-INR

92.29 0.37
(0.40%)

EUR-INR

106.44 -0.15
(-0.14%)

GBP-INR

123.36 -0.03
(-0.03%)

JPY-INR

0.58 0.00
(0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Hester Biosciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524669

INE782E01017

409.0776861

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

HESTERBIO

33.93

1199.47

EPS(TTM)

Face Value()

Div & Yield %

41.56

0.5

Back

Regent Enterprises standalone net profit rises 366.67% in the December 2025 quarter

Feb 13,2026

Net profit of Regent Enterprises rose 366.67% to Rs 1.82 crore in the quarter ended December 2025 as against Rs 0.39 crore during the previous quarter ended December 2024. Sales rose 21.38% to Rs 272.33 crore in the quarter ended December 2025 as against Rs 224.37 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	272.33	224.37	21
OPM %	0.71	0.10	-
PBDT	1.94	0.23	743
PBT	1.80	0.10	1700
NP	1.82	0.39	367

74,563.92 -1,470.50 ( -1.93%)

46,583.62 -115.24 (-0.25%)

6,653.27 -40.35 (-0.60%)

53,838.16 -614.80 (-1.13%)

10,249.42 -55.73 (-0.54%)

92.29 0.37 (0.40%)

106.44 -0.15 (-0.14%)

123.36 -0.03 (-0.03%)

0.58 0.00 (0.05%)